Get started
Author

Alan Lenox‐Smith

Observed names: A Lennox-Smith, A Lenox-Smith, A. J. Lenox-Smith, A. Lenox-Smith, A. Lenox‐Smith, A.J. Lenox-Smith, Alan J Lenox-Smith, Alan J. Lenox-Smith, Alan J. Lenox‐Smith, Alan Lenox-Smith, Alan Lenox-smith, Lenox-Smith Alan
OpenAlex ID: A5113610099
Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor
2008 · Alan J. Lenox-Smith, Qin Jiang · International Clinical Psychopharmacology · 64
A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care.
2003 · Alan J Lenox-Smith, Alan Reynolds · Europe PMC (PubMed Central) · 58
Health care resource utilisation in primary care prior to and after a diagnosis of Alzheimer’s disease: a retrospective, matched case–control study in the United Kingdom
2014 · Lei Chen, Catherine Reed, et al. · BMC Geriatrics · 53
PDF
Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double‐blind, placebo‐controlled trial
2014 · Karla J. Alaka, William Noble, et al. · International Journal of Geriatric Psychiatry · 46
PDF
Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials
2013 · Andrew J Bradley, Alan J Lenox-Smith · Journal of Psychopharmacology · 41
A review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety, suicide and mortality due to antidepressant overdose
2013 · David Taylor, Alan Lenox-Smith, et al. · Therapeutic Advances in Psychopharmacology · 36
PDF
Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
2015 · P. Marchettini, S. Wilhelm, et al. · European Journal of Pain · 35
Cost Effectiveness of Representatives of Three Classes of Antidepressants Used in Major Depression in the UK
2004 · Alan Lenox-Smith, Pete Conway, et al. · PharmacoEconomics · 32
Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer’s disease: 18-month UK results from the GERAS observational study
2016 · Alan Lenox-Smith, Catherine Reed, et al. · BMC Geriatrics · 30
Quality of Life in Depressed Patients in UK Primary Care: The FINDER Study
2013 · Alan Lenox-Smith, Mark T. B. Macdonald, et al. · Neurology and Therapy · 30
PDF
Pharmacoeconomic Analysis of Antidepressants for Major Depressive Disorder in the United Kingdom
2000 · Hugh Freeman, Steve Arikian, et al. · PharmacoEconomics · 30
Impact of patient selection and study characteristics on signal detection in placebo-controlled trials with antidepressants
2014 · Michele Mancini, Alan G. Wade, et al. · Journal of Psychiatric Research · 28
Potential cost savings to be made by slowing cognitive decline in mild Alzheimer’s disease dementia using a model derived from the UK GERAS observational study
2018 · Alan Lenox-Smith, Catherine Reed, et al. · BMC Geriatrics · 27
PDF
Individual residual symptoms and functional impairment in patients with depression
2014 · Irene Romera, Víctor Pérez, et al. · Psychiatry Research · 24
Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge
2010 · SD Hood, JK Melichar, et al. · Journal of Psychopharmacology · 24
Excess Costs Associated with Possible Misdiagnosis of Alzheimer’s Disease Among Patients with Vascular Dementia in a UK CPRD Population
2016 · Michael Happich, Noam Y. Kirson, et al. · Journal of Alzheimer s Disease · 17
PDF
Cost Effectiveness of Venlafaxine Compared with Generic Fluoxetine or Generic Amitriptyline in Major Depressive Disorder in the UK
2009 · Alan Lenox-Smith, Liz Greenstreet, et al. · Clinical Drug Investigation · 15
Cost-effectiveness of venlafaxine XL compared with diazepam in the treatment of generalised anxiety disorder in the United Kingdom
2005 · J. F. Guest, J. Russ, et al. · The European Journal of Health Economics · 14
Central noradrenergic responsiveness to a clonidine challenge in Generalized Anxiety Disorder: a Single Photon Emission Computed Tomography study
2011 · NJ Kalk, J Melichar, et al. · Journal of Psychopharmacology · 12
Treatment and outcomes for patients with depression who are partial responders to SSRI treatment: Post-hoc analysis findings from the FINDER European observational study
2014 · A. Lenox-Smith, J.M. Martinez, et al. · Journal of Affective Disorders · 11
Reliability of coded data to identify earliest indications of cognitive decline, cognitive evaluation and Alzheimer’s disease diagnosis: a pilot study in England
2018 · Grazia Dell’Agnello, Urvi Desai, et al. · BMJ Open · 7
PDF
Comparison of Ramipril Against Atenolol in Controlling Mild-to-Moderate Hypertension
1991 · A. J. Lenox-Smith, R. B. Street, et al. · Journal of Cardiovascular Pharmacology · 7
A 12-week nursing support programme for carers of children and adolescents in the UK with attention deficit hyperactivity disorder prescribed atomoxetine
2012 · Nicola Savill, Jeremy Pelton, et al. · Therapeutic Advances in Psychopharmacology · 6
A Review of the Serotonin-Norepinephrine Reuptake Inhibitors: Pharmacologic Aspects and Clinical Implications for Treatment of Major Depressive Disorder and Associated Painful Physical Symptoms
2013 · Levent Alev, Alan Lenox-Smith, et al. · Open Journal of Depression · 5
PDF
Psychotropic drug treatment
1998 · A. Lenox-Smith, T. Harris, et al. · BMJ · 3
Works count: 41
Citation count: 659
H-index: 16
I10-index: 20
Year
Topic
Type